Centre for Molecular Biosciences & Genomics

Meet the Team: Celestine Kemunto We are proud to introduce Celestine Kemunto, a Research Associate and Head of Operations at CMB Genomics. Celestine has been a driving force behind key initiatives at our organization, including the successful establishment of the CMB Genomics laboratory. Her work is central to our mission of increasing access to genomics and bioinformatics across Africa. Celestine holds a Bachelor’s degree in Microbiology and Biotechnology and is currently pursuing a Master’s degree in Medical Microbiology. Her passion lies in research that improves health outcomes in low-resource settings, particularly in Africa. At Yemaachi Biotech, Celestine supports cancer research aimed at advancing precision oncology. She is especially committed to improving women’s health, particularly in vulnerable populations. Currently, she leads a project funded by CMB Genomics investigating the prevalence, genetic diversity, and risk factors associated with HPV infections among women with HIV in Meru, Kenya. She is also conducting a cost analysis study on HPV PCR testing in rural Kenya. Her dedication has earned her recognition, including a new investigator scholarship that allowed her to present her preliminary findings at the Conference on Retroviruses and Opportunistic Infections (CROI) in Colorado, USA, earlier this year. Most recently, she received a scholarship from the Aga Khan University Fogarty Training Program to pursue advanced training in HPV epidemiology and biostatistics at the University of Washington, Seattle. This opportunity, starting in September 2024, will enable her to conduct advanced analyses and publish her findings. Celestine is skilled in a wide range of molecular biology techniques, including nucleic acid extraction, PCR, and sequencing technologies like Sanger, Oxford Nanopore, and Illumina. She has a keen interest in bioinformatics and has completed several courses, including Introduction to Bioinformatics by H3ABioNet and MalariaGEN-PAMCA's Data Analysis for Genomic Surveillance of African Malaria Vectors. Beyond her research, Celestine is dedicated to mentoring the next generation of African scientists and actively participates in training programs to build local capacity in genomics and bioinformatics. In her free time, she enjoys cooking and volunteering in community-focused initiatives. As Celestine approaches the completion of her Master’s degree this year, she is actively seeking mentors and funding opportunities for her PhD studies. She is eager to explore microbial and epigenetic markers associated with HPV infection, cervical dysplasia, and cancer. #WomensHealth #WomeninSTEM #HPV #Cervicalcancer #Genomics #Bioinformatics #Epidemiology #Biostatistics #Africa #Kenya

The Role of Next Generation Sequencing in Understanding and Controlling the Monkeypox Outbreak As the monkeypox outbreak continues to present significant challenges to public health systems worldwide, understanding the virus at a molecular level has become crucial in developing effective containment and treatment strategies. Next-generation sequencing can enable scientists to decode the entire genome of the monkeypox virus. This technology not only aids in the accurate identification of the virus but also provides insights into its genetic variations, transmission dynamics, and potential resistance to treatments. By understanding the genetic makeup of the monkeypox virus, researchers and public health officials can track its evolution and spread, which is essential for developing targeted vaccines and therapies. Therefore, integrating NGS with other molecular diagnostic tools ensures a comprehensive approach to managing the outbreak. Contact us on +254 743529576 or email us at info@cmbgenomics.org to learn more about us. #Monkeypox #Mpox #Genomics #Bioinformatics #Surveillance #NGS #Molecularbiology #Epidemiology #Africa #Kenya

Detecting and Managing Monkeypox: CMB Genomics' Role in Responding to Outbreaks The recent outbreaks of #monkeypox (Mpox) across various regions have raised significant public health concerns, particularly due to its rapid spread and potential for severe health outcomes. At CMB Genomics, a clinical diagnostics and research startup based in Nairobi, Kenya, we are at the forefront of developing and deploying innovative diagnostic solutions to manage and contain such infectious diseases. Monkeypox is a zoonotic disease caused by the monkeypox virus, mainly found in East and Central Africa. Mpox is characterised by symptoms such as: swollen lymph nodes, rashes and fever. It's transmitted through physical contact, sexual intercourse, contact with infected animals and mother-to-child transmission. Early detection is crucial in managing the spread of this virus, and CMB Genomics is capable of offering PCR-based assays and genomic sequencing, to provide accurate and timely diagnostics for Mpox. CMB Genomics is dedicated to contributing to the health and well-being of communities by providing advanced diagnostics and fostering a robust biomedical research platform in Africa. Together, we can detect, manage, and ultimately control the spread of diseases like monkeypox. Contact us on 0743 529 576 or info@cmbgenomics.org to learn more. #Monkeypox #Genomics #MolecularBiology #MolecularDiagnostics #Publichealth

Exciting Collaboration Opportunity Today we met with faculty members from the the Department of Natural Science at the Catholic University of Eastern Africa (CUEA) to discuss potential collaboration opportunities. We seek to partner through joint research and capacity building through training. This collaboration will be instrumental in fostering partnership between academia and industry. James SIFUNA Sophia Mogere Nyasore Stephen Gitahi Njuguna Adele #Collaboration #Partnership #Research #Capacitybuilding #Academia #Industry

Exciting Collaboration Opportunity Today we met with faculty members from the the Department of Natural Science at the Catholic University of Eastern Africa (CUEA) to discuss potential collaboration opportunities. We seek to partner through joint research and capacity building through training. This collaboration will be instrumental in fostering partnership between academia and industry. James SIFUNA Sophia Mogere Nyasore Stephen Gitahi Njuguna Adele #Collaboration #Partnership #Research #Capacitybuilding #Academia #Industry

Are you a Master's or PhD student looking for a molecular laboratory to do your project work? Contact us today via email or on 0743 529 576. #MolecularBiology #Genomics #PCR #Sequencing

Genomics and the Fight Against Antimicrobial Resistance   Antimicrobial resistance (AMR) is currently one of the biggest threats to public health. The misuse of antibiotics has led to the development of AMR since the advent of antibiotics. By 2050, it is estimated that 10 million deaths will occur annually due to #AMR. Infections such as TB and STIs are increasingly becoming difficult to treat due to the emergence of AMR. #Genomics is a powerful tool in the fight against AMR, offering useful data into the mechanisms of AMR and the development of new drugs through the identification of potential drug targets. By sequencing the genomes of pathogens, researchers can identify specific genetic #mutations that confer resistance to antibiotics. This information is crucial for developing targeted drugs, guiding the use of existing drugs, and tracking the spread of resistant strains in real-time. Moreover, genomic data can aid in the discovery of new antibiotics and alternative treatments, providing hope in the fight against AMR. Collaborative efforts in genomics research are essential to combat the evolving threat of resistance and safeguard public health for future generations. Contact us at CMB Genomics to learn more about our infrastructure projects and explore partnership opportunities. Let’s build a brighter future for genomic research in Africa. Reference:  UNEP: https://lnkd.in/dws9t4gB. #Genomics #AntimicrobialResistance #AMR #PublicHealth #GenomicResearch #InfectiousDiseases #HealthcareInnovation #CMBGenomics #Africa #Kenya

The Application of Genomics in Public Health Policy Genomics research is improving public health policy and decision-making especially in first world countries. By providing insights into the genetic causes of diseases, genomics enables the development of targeted interventions and personalized medicine, leading to more effective treatments and prevention strategies. Public health policies are increasingly leveraging genomic data to identify at-risk populations, track disease outbreaks, predict epidemics and pandemics and develop vaccines. This precision in understanding and addressing health issues enhances the efficiency and impact of health programs. Moreover, genomics informs policy by highlighting the need for equitable access to genetic testing and personalized treatments, ensuring that advancements benefit all segments of the population. The integration of genomics into public health strategies also fosters collaborations between researchers, healthcare providers, and policymakers, promoting a comprehensive approach to health management. As genomic research continues to evolve, its influence on public health policy will undoubtedly grow, paving the way for a healthier future. At CMB Genomics, we invite academic institutions, funding agencies, and industry partners to join us in building robust research infrastructure for genomics in Africa. By working together, we can create a strong foundation for scientific innovation and improve health outcomes across the continent. Contact us at CMB Genomics to learn more about our infrastructure projects and explore partnership opportunities. Let’s build a brighter future for genomic research in Africa. #Publichealth #Policy #Research #Genomics #Innovation #CMBGenomics #Africa #Kenya

Our 5-day training aims to enhance your knowledge and practical skills in molecular biology. Sign up today by filling this form: https://lnkd.in/deTEcp2N

Empowering Women in Science The field of genomics and bioinformatics is rapidly evolving, and women are playing a crucial role in driving this progress. Empowering women in these fields is not only a matter of equity but also a strategic imperative for advancing scientific discovery and innovation. At CMB Genomics, we are committed to supporting and highlighting the contributions of women in genomics, molecular biology and bioinformatics. We have worked with Hellen Wambui, who is pursuing a PhD in Medical Microbiology at the University of Nairobi. Her research is based on the association between female genital schistosomiasis (FGS) and HPV infection among women of reproductive age in Kilifi County. Her work aims to bring awareness to FGS and its impact on female reproductive health. Additionally, CMB Genomics has supported Celestine Kemunto’s research project. She is a Master’s student at Kenyatta University, pursuing Medical Microbiology. Her research is investigating the prevalence, risk factors and genetic diversity of high-risk HPV genotypes in women living with HIV in Meru County. Her project will be instrumental in informing guidelines for cervical cancer screening and management among women with HIV. Empowering women in genomics and bioinformatics is essential for building a diverse and inclusive scientific community. Diversity brings different perspectives and ideas, which are crucial for innovation and problem-solving. At CMB Genomics, we believe that by supporting women, we are investing in the future of genomics research and healthcare. We invite academic institutions, funding agencies, and industry partners to join us in our efforts to empower women in genomics. By collaborating with us, you can help provide more opportunities for women to contribute to and lead in the fields of genomics and bioinformatics. Contact us at CMB Genomics to learn more about our initiatives and explore partnership opportunities. Let’s work together to empower the next generation of women in genomics. Global Schistosomiasis Alliance #Genomics #MolecularBiology #AfricanWomenInScience #AfricanWomenInSTEM #Bioinformatics #Diversity #Inclusion #CMBGenomics #Africa #Kenya #Nairobi